HUA MEDICINE
(HKEX: 2552)
Hua Medicine Ltd. provides drug discovery and development services. It offers drugs for diabetes and Central Nervous System disorders. Its products include Dorzagliatin HMS552, Dorzagliatin+Metformin, Dorzagliatin+DPPIV, Dorzagliatin+SGLT-2, Dorzagliatin+Insulin, Dorzagliatin+GLP-1 and mGLUR5 NAM. The company was founded by Chen Li on November 10, 2009 and is headquartered in Shanghai, China.
3.540 -
-0.080
(-2.21%)
Range
3.480 - 3.620
(4.02%)
Open
3.600
Previous Close
3.620
Bid Price
3.510
Bid Volume
('000)
9
Ask Price
3.550
Ask Volume
('000)
2.5
Volume
('000)
2,755.4
Value
9,719,878
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
